NCT01192373 - "Modulation of Free Fatty Acids in Heart Failure Patients With Diabetes: Effect on Left Ventricular Function" | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2012

Conditions

Heart FailureDiabetes

Interventions

OTHER

Metabolic substrate modulation

for high circulation free fatty acids: Heparin (250IE/hour) + intralipid (20%, 62 ml/hour).

OTHER

metabolic substrate modulation

low circulating free acids: hyperinsulinaemic euglycemic clamp (0,8 mUkg/min) with venous blood glucose at 4,5-6,5 mM.

Trial Locations (1)

Dept. of cardiology, Aarhus University hospital Skejby,, Aarhus